Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Frontiers in Genetics|October 5, 2020
Variation rs2235503 C > A Within the Promoter of <i>MSLN</i> Affects Transcriptional Rate of Mesothelin and Plasmatic Levels of the Soluble Mesothelin-Related PeptideRoberto Silvestri, Perla Pucci, Chiara De Santi, et al.
Epigenomics|January 29, 2025
EZH2 inhibition enhances the activity of Carboplatin in aggressive-variant prostate cancer cell linesMaryam Latarani, Perla Pucci, Mark Eccleston, et al.
Plos One|November 27, 2024
REST-dependent glioma progression occurs independently of the repression of the long non-coding RNA HAR1AElla Waters, Perla Pucci, Ruman Rahman, et al.
Occupational and Environmental Medicine|March 27, 2017
Mesothelin promoter variants are associated with increased soluble mesothelin-related peptide levels in asbestos-exposed individualsChiara De Santi, Perla Pucci, Alessandra Bonotti, et al.
Molecular Cancer|May 4, 2025
The anti-diabetic PPARγ agonist Pioglitazone inhibits cell proliferation and induces metabolic reprogramming in prostate cancerEmine Atas, Kerstin Berchtold, Michaela Schlederer, et al.
The EMBO Journal|November 11, 2024
METTL3/MYCN cooperation drives neural crest differentiation and provides therapeutic vulnerability in neuroblastomaKetan Thombare, Roshan Vaid, Perla Pucci, et al.
Nature Communications|April 23, 2024
Targeting NRAS via miR-1304-5p or farnesyltransferase inhibition confers sensitivity to ALK inhibitors in ALK-mutant neuroblastomaPerla Pucci, Liam C Lee, Miaojun Han, et al.
Molecular Oncology|April 1, 2021
The evolutionarily conserved long non-coding RNA LINC00261 drives neuroendocrine prostate cancer proliferation and metastasis via distinct nuclear and cytoplasmic mechanismsRebecca L Mather, Abhijit Parolia, Sandra E Carson, et al.
Pageof 2